Guy Launoy
Pr Guy Launoy, PhD is an expert in Oncology at Centre François Baclesse (France). As of September 2026, ScienceLeadR ranks Guy Launoy in the top 1% of experts worldwide for Rectal Diseases, Intestinal Neoplasms and Gastrointestinal Neoplasms. Guy Launoy has authored 306 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 868 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1989 - 2026
Number : 306
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Clustering of COVID-19 testing and incidence time series: a method to understand epidemic dynamics at the territorial scale. PMID 42800401 — research design, principal component analysis, incidence, public health, covid-19, cluster analysis, covid-19 testing, communicable diseases, epidemics, negotiating | Epidemics | 2026 | 0 |
| Social Inequalities, Geographical Accessibility to Care, and Excess Mortality for Patients With Hematological Malignancies in France: Results From French Cancer Registries. PMID 42758869 — registries, travel, cells, lymphoma, follicular, mortality, hematology, hematologic neoplasms, lymphoma, lymphoma, large b-cell, diffuse, neoplasms, environment | Hematol Oncol | 2026 | 0 |
| Cancer Patients Mortality From Other Causes: A European Population-Based Study. PMID 42734108 — registries, urinary bladder, mortality, lung, stomach, ovary, neoplasms, prostate, kidney, breast, cervix uteri | Cancer Med | 2026 | 0 |
| Use of population-based cancer registry data to evaluate organized breast cancer screening programmes in Europe by mode of detection: a scoping review. PMID 42309527 — registries, bias, epidemiology, breast neoplasms, neoplasms, public health, breast | Eur J Public Health | 2026 | 0 |
| Development of an intervention theory for a mobile mammography unit research project for breast cancer screening. PMID 42053923 — breast neoplasms, neoplasms, mammography, public health, breast, research | Can J Public Health | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Randomized Cluster Trial to Evaluate a Mobile Mammography Unit in Breast Cancer Screening in France (Mammobile) NCT05164874 — clinical protocols, breast neoplasms, neoplasms, mammography, breast, research, complement system proteins | N/A | Enrolling by invitation | 2022 |
LeadR Networks
Main global connection map